Klinische Studie

PROOFS-Registry - Premenopausal women with breast cancer optimally treated with OFS(PROOFS)PROOFS-Registry - Premenopausal women with breast cancer optimally treated with ovarian fintcion suppression (OFS)
Krankheitsentität(en) Brust
StudientypBeobachtungsstudie
Wesentliche Einschlusskriterien- Female breast cancer patients - Pre- or perimenopausal at registry entry (age <60 years and state after hysterectomy or amenorrhea for <12 months: confirmation by blood hormone levels (FSH and estradiol in premenopausal range as per local normal range) recommended) - Primary tumor diagnosis not older than three months prior to inclusion (primary diagnosis defined as date of initial tumor biopsy) - Estrogen- and/or progesterone-receptor-positive/HER2 negative early breast cancer without any clinical signs of metastases
Wesentliche Ausschlusskriterien- Any other genomic testing, besides MammaPrint®/BluePrint®, has been performed on the tumor material - Medical or psychological conditions that would not permit the patient to sign informed consent - Legal incapacity or limited legal capacity - Current participation in any interventional clinical trial which tests anticancer drugs, immunotherapeutics, or antibody treatment for any type of neoplasm - Non-compliance of the patient
Statusrekrutierend
Ansprechpartner & KontaktCaritas-Krankenhaus St. Josef RegensburgFrauenheilkunde und Geburtshilfe Krankenhaus St JosefStudienzentrale0941 7823403fhk-studienzentrum(at)csj.de
zurück